July 10, 2021
by Alex Brown
Biopharma insight
The antibody-drug conjugates (ADCs) market continues to rise globally, but ADCs are not a new thing. Why has ADC been surging …
May 24, 2021
by Irina Bilous
Biopharma insight
The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even …
April 15, 2021
by Aruna Rajan
Biopharma insight
2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome …
March 28, 2021
by Andrii Buvailo
Interview
The team at Insilico Medicine has recently reported that they achieved a major milestone for their comprehensive artificial intelligence (AI)-based …
March 24, 2021
by Leo Cole
Biopharma insight
Did you know? According to a study from Accenture, 60% of patients would prefer access to care via telehealth technology …
March 19, 2021
by Amandeep Singh
Biopharma insight
The AI drug discovery industry has already gathered momentum with AI start-ups having signed more than 200 deals with 50+ …
March 15, 2021
by Satnam Surae
Biopharma insight
Covid-19 is still having a devastating effect on many countries and economies worldwide and has brought to light the impact …
Feb. 11, 2021
by Andrii Buvailo
Biopharma insight
A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to …
Dec. 7, 2020
by William Patrick Slattery
Biopharma insight
Artificial Intelligence (A.I.) has revolutionized many industries as we speak, which doesn't exclude pharmaceuticals. However, unlike other sectors concerning Information …
Nov. 29, 2020
by Andrii Buvailo
Biopharma insight
Table of Contents: Introduction The abundance of venture capital, major funding rounds New AI-driven biotech startups founded in 2020 Notable …
Oct. 5, 2020
by Amandeep Singh
Biopharma insight
The pharmaceutical business is one of the riskiest industries to venture into. Drug discovery is an artisanal process where a …
Sept. 14, 2020
by Raj Indupuri
Biopharma insight
How life sciences companies are reimagining trials during the biggest health crisis in a century Whatever the world was like …